Article Details

Japan's PeptiDream inks $40 M deal with Genentech for novel peptide-radioisotope drug conjugates

Retrieved on: 2023-09-20 13:27:19

Tags for this article:

Click the tags to see associated articles and topics

Japan's PeptiDream inks $40 M deal with Genentech for novel peptide-radioisotope drug conjugates. View article details on hiswai:

Excerpt

BioTech · Biologics · Stem Cells · Vaccines · Therapeutics · MedTech · Medical ... peptide-radioisotope (peptide-RI) drug conjugates. Under the ...

Article found on: www.biospectrumasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up